Data on optimization of expression and purification of AIMP2-DX2 protein in Escherichia coli

Roshan Jha1, Hye Young Cho1, Ameeq Ul Mushtaq1

  • 1College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong 30019, Republic of Korea.

Data in Brief
|April 4, 2017
PubMed

Insights

This study details the expression and purification of the AIMP2-DX2 protein in E. coli. Optimized methods yielded highly pure AIMP2-DX2 for further biophysical characterization.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Protein Expression

Background:

  • AIMP2-DX2 is a splicing variant of the AIMP2 protein.
  • AIMP2-DX2 has been linked to human lung cancer and chemoresistance in ovarian cancer.
  • Previous studies indicated the involvement of AIMP2-DX2 in these diseases.

Purpose of the Study:

  • To describe the expression of AIMP2-DX2 protein in Escherichia coli.
  • To optimize critical purification steps for AIMP2-DX2.
  • To provide data for subsequent biophysical characterization of AIMP2-DX2.

Main Methods:

  • Expression of AIMP2-DX2 in E. coli.
  • Optimization of protein purification protocols.
  • Yield maximization and purity assessment of AIMP2-DX2.

Main Results:

  • Successful expression of AIMP2-DX2 in E. coli.
  • Identified and optimized critical steps for AIMP2-DX2 purification.
  • Achieved maximum yield of highly pure AIMP2-DX2 protein.

Conclusions:

  • The optimized purification protocol enables high-yield production of pure AIMP2-DX2.
  • The generated data supports further biophysical characterization of AIMP2-DX2.
  • This work facilitates future research into the role of AIMP2-DX2 in cancer.

Related Concept Videos